Details for: SELL

Gene ID: 6402

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: SELL

Ensembl ID: ENSG00000188404

Description: selectin L

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • CD16-negative, CD56-bright natural killer cell, human CL0000938
    CSI 103.87
    rCSI 77.89%
    PRS 20.45
  • hematopoietic stem cell CL0000037
    CSI 78.16
    rCSI 51.95%
    PRS 8.23
  • naive thymus-derived CD8-positive, alpha-beta T cell CL0000900
    CSI 65.99
    rCSI 46.35%
    PRS 19.79
  • plasmacytoid dendritic cell, human CL0001058
    CSI 56.25
    rCSI 39.27%
    PRS 7.29
  • class switched memory B cell CL0000972
    CSI 49
    rCSI 36.58%
    PRS 11.72
  • naive B cell CL0000788
    CSI 40.78
    rCSI 34.98%
    PRS 15.63
  • naive thymus-derived CD4-positive, alpha-beta T cell CL0000895
    CSI 39.52
    rCSI 49.66%
    PRS 34.73
  • mature B cell CL0000785
    CSI 37.51
    rCSI 32.61%
    PRS 8.53
  • promonocyte CL0000559
    CSI 34.19
    rCSI 58.57%
    PRS 9.28
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 30.08
    rCSI 17.77%
    PRS 9.6
  • plasmacytoid dendritic cell CL0000784
    CSI 23.79
    rCSI 24.1%
    PRS 41.67
  • double negative thymocyte CL0002489
    CSI 21.52
    rCSI 14.96%
    PRS 8.1
  • common dendritic progenitor CL0001029
    CSI 21.22
    rCSI 26.63%
    PRS 8.81
  • group 3 innate lymphoid cell CL0001071
    CSI 15.25
    rCSI 11.46%
    PRS 7.12
  • CD4-positive helper T cell CL0000492
    CSI 15.22
    rCSI 11.51%
    PRS 9.63
  • follicular B cell CL0000843
    CSI 15.13
    rCSI 55.01%
    PRS 31.5
  • CD14-positive, CD16-negative classical monocyte CL0002057
    CSI 11.08
    rCSI 67.03%
    PRS 16.11
  • T-helper 17 cell CL0000899
    CSI 10.7
    rCSI 8.5%
    PRS 12.23
  • regulatory T cell CL0000815
    CSI 9.97
    rCSI 11.56%
    PRS 22.85
  • memory B cell CL0000787
    CSI 9.8
    rCSI 9.68%
    PRS 29.19
  • early lymphoid progenitor CL0000936
    CSI 8.94
    rCSI 7.85%
    PRS 7.77
  • classical monocyte CL0000860
    CSI 8.66
    rCSI 12.84%
    PRS 58.28
  • CD16-positive, CD56-dim natural killer cell, human CL0000939
    CSI 8.56
    rCSI 5.71%
    PRS 19.18
  • effector memory CD4-positive, alpha-beta T cell CL0000905
    CSI 8.12
    rCSI 11.06%
    PRS 17.22
  • hematopoietic precursor cell CL0008001
    CSI 7.92
    rCSI 8.15%
    PRS 11.24
  • CD4-positive, alpha-beta thymocyte CL0000810
    CSI 7.8
    rCSI 6.25%
    PRS 12.71
  • innate lymphoid cell CL0001065
    CSI 6.98
    rCSI 14.42%
    PRS 10.98
  • gamma-delta T cell CL0000798
    CSI 6.78
    rCSI 7.96%
    PRS 53.96
  • thymocyte CL0000893
    CSI 6.77
    rCSI 24.05%
    PRS 22.42
  • activated CD4-positive, alpha-beta T cell CL0000896
    CSI 6.63
    rCSI 6.13%
    PRS 12.67
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 6.09
    rCSI 4.1%
    PRS 8.36
  • transitional stage B cell CL0000818
    CSI 5.92
    rCSI 19.38%
    PRS 20.82
  • CD4-positive, alpha-beta memory T cell CL0000897
    CSI 5.72
    rCSI 4.11%
    PRS 9.41
  • CD8-positive, alpha-beta memory T cell CL0000909
    CSI 5.52
    rCSI 5.76%
    PRS 21.83
  • dendritic cell CL0000451
    CSI 5.18
    rCSI 6.38%
    PRS 23.27
  • unswitched memory B cell CL0000970
    CSI 5.04
    rCSI 4.24%
    PRS 11.53
  • common lymphoid progenitor CL0000051
    CSI 4.77
    rCSI 6.38%
    PRS 13.25
  • B cell CL0000236
    CSI 4.43
    rCSI 5.93%
    PRS 35.58
  • CD14-positive monocyte CL0001054
    CSI 4.27
    rCSI 5.31%
    PRS 10.03
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 4.14
    rCSI 16.13%
    PRS 11.47
  • hematopoietic multipotent progenitor cell CL0000837
    CSI 3.93
    rCSI 9.45%
    PRS 11.01
  • myeloid lineage restricted progenitor cell CL0000839
    CSI 3.81
    rCSI 19.68%
    PRS 13.9
  • double negative T regulatory cell CL0011024
    CSI 3.77
    rCSI 71.72%
    PRS 49.01
  • IgG plasma cell CL0000985
    CSI 3.61
    rCSI 4.32%
    PRS 12.07
  • immature B cell CL0000816
    CSI 3.43
    rCSI 2.55%
    PRS 10.38
  • mature NK T cell CL0000814
    CSI 3.23
    rCSI 4.14%
    PRS 31.1
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI 3.21
    rCSI 3.15%
    PRS 11.02
  • monocyte CL0000576
    CSI 3.08
    rCSI 5.57%
    PRS 19.59
  • conventional dendritic cell CL0000990
    CSI 2.95
    rCSI 2.46%
    PRS 21.98
  • T follicular helper cell CL0002038
    CSI 2.86
    rCSI 2.14%
    PRS 11.31
  • effector CD8-positive, alpha-beta T cell CL0001050
    CSI 2.84
    rCSI 2.16%
    PRS 9.17
  • naive T cell CL0000898
    CSI 2.74
    rCSI 1.91%
    PRS 10
  • plasmablast CL0000980
    CSI 2.61
    rCSI 2.05%
    PRS 8.24
  • IgA plasma cell CL0000987
    CSI 2.44
    rCSI 2.5%
    PRS 13.13
  • inflammatory macrophage CL0000863
    CSI 2.27
    rCSI 3.87%
    PRS 14.32
  • pro-B cell CL0000826
    CSI 2.14
    rCSI 1.77%
    PRS 6.94
  • erythrocyte CL0000232
    CSI 2.09
    rCSI 4.75%
    PRS 9.9
  • activated CD4-positive, alpha-beta T cell, human CL0001043
    CSI 2.01
    rCSI 4.84%
    PRS 44.18
  • activated CD8-positive, alpha-beta T cell CL0000906
    CSI 1.96
    rCSI 1.93%
    PRS 20.5
  • myeloid dendritic cell CL0000782
    CSI 1.96
    rCSI 2.84%
    PRS 10.19
  • megakaryocyte CL0000556
    CSI 1.94
    rCSI 8.4%
    PRS 12.8
  • neutrophil CL0000775
    CSI 1.93
    rCSI 10.78%
    PRS 18.98
  • mononuclear phagocyte CL0000113
    CSI 1.83
    rCSI 4.02%
    PRS 7.59
  • effector memory CD8-positive, alpha-beta T cell CL0000913
    CSI 1.56
    rCSI 1.42%
    PRS 10.8
  • promyelocyte CL0000836
    CSI 1.45
    rCSI 2.1%
    PRS 9.66
  • dendritic cell, human CL0001056
    CSI 1.33
    rCSI 2.05%
    PRS 8.06
  • myeloid leukocyte CL0000766
    CSI 1.29
    rCSI 1.19%
    PRS 7.02
  • professional antigen presenting cell CL0000145
    CSI 1.27
    rCSI 4.38%
    PRS 29.83
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI 1.19
    rCSI 2.04%
    PRS 14.88
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 0.97
    rCSI 1.94%
    PRS 11.83
  • helper T cell CL0000912
    CSI 0.93
    rCSI 1.31%
    PRS 10.02
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 0.92
    rCSI 0.83%
    PRS 6.11
  • basophil CL0000767
    CSI 0.92
    rCSI 1.94%
    PRS 14.91
  • common myeloid progenitor CL0000049
    CSI 0.88
    rCSI 0.71%
    PRS 6.8
  • intermediate monocyte CL0002393
    CSI 0.87
    rCSI 1.31%
    PRS 6.82
  • granulocyte monocyte progenitor cell CL0000557
    CSI 0.84
    rCSI 0.73%
    PRS 7.7
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 0.71
    rCSI 0.86%
    PRS 10
  • CD4-positive, alpha-beta cytotoxic T cell CL0000934
    CSI 0.68
    rCSI 0.93%
    PRS 14.71
  • myeloid dendritic cell, human CL0001057
    CSI 0.67
    rCSI 3.77%
    PRS 22.57
  • mature alpha-beta T cell CL0000791
    CSI 0.6
    rCSI 2.18%
    PRS 11.97
  • B-2 B cell CL0000822
    CSI 0.58
    rCSI 12.23%
    PRS 41.01
  • B-1 B cell CL0000819
    CSI 0.52
    rCSI 13.53%
    PRS 37.9
  • germinal center B cell CL0000844
    CSI 0.52
    rCSI 1.56%
    PRS 18.19
  • granulocyte CL0000094
    CSI 0.51
    rCSI 0.78%
    PRS 8.7
  • effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL0001062
    CSI 0.51
    rCSI 2.54%
    PRS 9.08
  • group 2 innate lymphoid cell CL0001069
    CSI 0.5
    rCSI 2.71%
    PRS 24.38
  • cytotoxic T cell CL0000910
    CSI 0.48
    rCSI 2.77%
    PRS 10.5
  • IgM plasma cell CL0000986
    CSI 0.47
    rCSI 2.12%
    PRS 36.12
  • eosinophil CL0000771
    CSI 0.38
    rCSI 2.51%
    PRS 18.37
  • CD8-alpha-alpha-positive, alpha-beta intraepithelial T cell CL0000915
    CSI 0.33
    rCSI 1.48%
    PRS 25.79
  • fraction A pre-pro B cell CL0002045
    CSI 0.31
    rCSI 0.36%
    PRS 14.36
  • erythroid progenitor cell CL0000038
    CSI 0.13
    rCSI 0.73%
    PRS 10.86
  • large pre-B-II cell CL0000957
    CSI 0.12
    rCSI 0.34%
    PRS 12.33
  • CD14-low, CD16-positive monocyte CL0002396
    CSI -0.04
    rCSI -0.03%
    PRS 6.25
  • mature T cell CL0002419
    CSI -0.18
    rCSI -0.14%
    PRS 9.92
  • alpha-beta T cell CL0000789
    CSI -0.82
    rCSI -0.96%
    PRS 10.38
  • CD8-positive, alpha-beta thymocyte CL0000811
    CSI -1.09
    rCSI -1.69%
    PRS 17.67
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI -3.65
    rCSI -4.41%
    PRS 8.14
  • precursor B cell CL0000817
    CSI -5.49
    rCSI -4.81%
    PRS 9.3
  • platelet CL0000233
    CSI -8.55
    rCSI -35.47%
    PRS 18.18
  • non-classical monocyte CL0000875
    CSI -9.9
    rCSI -15.8%
    PRS 22.8%
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI -8.9
    rCSI -11.7%
    PRS 9.7%
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI -8.8
    rCSI -10.5%
    PRS 12.1%
  • platelet CL0000233
    CSI -8.6
    rCSI -35.5%
    PRS 18.2%
  • precursor B cell CL0000817
    CSI -5.5
    rCSI -4.8%
    PRS 9.3%
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI -3.7
    rCSI -4.4%
    PRS 8.1%
  • CD8-positive, alpha-beta thymocyte CL0000811
    CSI -1.1
    rCSI -1.7%
    PRS 17.7%
  • alpha-beta T cell CL0000789
    CSI -0.8
    rCSI -1.0%
    PRS 10.4%
  • mature T cell CL0002419
    CSI -0.2
    rCSI -0.1%
    PRS 9.9%
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 0.0
    rCSI 0.0%
    PRS 6.3%
  • large pre-B-II cell CL0000957
    CSI 0.1
    rCSI 0.3%
    PRS 12.3%
  • erythroid progenitor cell CL0000038
    CSI 0.1
    rCSI 0.7%
    PRS 10.9%
  • fraction A pre-pro B cell CL0002045
    CSI 0.3
    rCSI 0.4%
    PRS 14.4%
  • CD8-alpha-alpha-positive, alpha-beta intraepithelial T cell CL0000915
    CSI 0.3
    rCSI 1.5%
    PRS 25.8%
  • eosinophil CL0000771
    CSI 0.4
    rCSI 2.5%
    PRS 18.4%
  • IgM plasma cell CL0000986
    CSI 0.5
    rCSI 2.1%
    PRS 36.1%
  • cytotoxic T cell CL0000910
    CSI 0.5
    rCSI 2.8%
    PRS 10.5%
  • group 2 innate lymphoid cell CL0001069
    CSI 0.5
    rCSI 2.7%
    PRS 24.4%
  • effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL0001062
    CSI 0.5
    rCSI 2.5%
    PRS 9.1%
  • granulocyte CL0000094
    CSI 0.5
    rCSI 0.8%
    PRS 8.7%
  • germinal center B cell CL0000844
    CSI 0.5
    rCSI 1.6%
    PRS 18.2%
  • B-1 B cell CL0000819
    CSI 0.5
    rCSI 13.5%
    PRS 37.9%
  • B-2 B cell CL0000822
    CSI 0.6
    rCSI 12.2%
    PRS 41.0%
  • mature alpha-beta T cell CL0000791
    CSI 0.6
    rCSI 2.2%
    PRS 12.0%
  • myeloid dendritic cell, human CL0001057
    CSI 0.7
    rCSI 3.8%
    PRS 22.6%
  • CD4-positive, alpha-beta cytotoxic T cell CL0000934
    CSI 0.7
    rCSI 0.9%
    PRS 14.7%
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 0.7
    rCSI 0.9%
    PRS 10.0%
  • granulocyte monocyte progenitor cell CL0000557
    CSI 0.8
    rCSI 0.7%
    PRS 7.7%
  • intermediate monocyte CL0002393
    CSI 0.9
    rCSI 1.3%
    PRS 6.8%
  • common myeloid progenitor CL0000049
    CSI 0.9
    rCSI 0.7%
    PRS 6.8%
  • basophil CL0000767
    CSI 0.9
    rCSI 1.9%
    PRS 14.9%
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 0.9
    rCSI 0.8%
    PRS 6.1%
  • helper T cell CL0000912
    CSI 0.9
    rCSI 1.3%
    PRS 10.0%
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 1.0
    rCSI 1.9%
    PRS 11.8%
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI 1.2
    rCSI 2.0%
    PRS 14.9%
  • professional antigen presenting cell CL0000145
    CSI 1.3
    rCSI 4.4%
    PRS 29.8%
  • myeloid leukocyte CL0000766
    CSI 1.3
    rCSI 1.2%
    PRS 7.0%
  • dendritic cell, human CL0001056
    CSI 1.3
    rCSI 2.1%
    PRS 8.1%
  • promyelocyte CL0000836
    CSI 1.5
    rCSI 2.1%
    PRS 9.7%
  • effector memory CD8-positive, alpha-beta T cell CL0000913
    CSI 1.6
    rCSI 1.4%
    PRS 10.8%
  • mononuclear phagocyte CL0000113
    CSI 1.8
    rCSI 4.0%
    PRS 7.6%
  • neutrophil CL0000775
    CSI 1.9
    rCSI 10.8%
    PRS 19.0%
  • megakaryocyte CL0000556
    CSI 1.9
    rCSI 8.4%
    PRS 12.8%
  • myeloid dendritic cell CL0000782
    CSI 2.0
    rCSI 2.8%
    PRS 10.2%
  • activated CD8-positive, alpha-beta T cell CL0000906
    CSI 2.0
    rCSI 1.9%
    PRS 20.5%
  • activated CD4-positive, alpha-beta T cell, human CL0001043
    CSI 2.0
    rCSI 4.8%
    PRS 44.2%
  • erythrocyte CL0000232
    CSI 2.1
    rCSI 4.8%
    PRS 9.9%
  • pro-B cell CL0000826
    CSI 2.1
    rCSI 1.8%
    PRS 6.9%
  • inflammatory macrophage CL0000863
    CSI 2.3
    rCSI 3.9%
    PRS 14.3%
  • IgA plasma cell CL0000987
    CSI 2.4
    rCSI 2.5%
    PRS 13.1%
  • plasmablast CL0000980
    CSI 2.6
    rCSI 2.1%
    PRS 8.2%
  • naive T cell CL0000898
    CSI 2.7
    rCSI 1.9%
    PRS 10.0%
  • effector CD8-positive, alpha-beta T cell CL0001050
    CSI 2.8
    rCSI 2.2%
    PRS 9.2%
  • T follicular helper cell CL0002038
    CSI 2.9
    rCSI 2.1%
    PRS 11.3%
  • conventional dendritic cell CL0000990
    CSI 3.0
    rCSI 2.5%
    PRS 22.0%
  • monocyte CL0000576
    CSI 3.1
    rCSI 5.6%
    PRS 19.6%
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI 3.2
    rCSI 3.2%
    PRS 11.0%
  • mature NK T cell CL0000814
    CSI 3.2
    rCSI 4.1%
    PRS 31.1%
  • immature B cell CL0000816
    CSI 3.4
    rCSI 2.6%
    PRS 10.4%
  • IgG plasma cell CL0000985
    CSI 3.6
    rCSI 4.3%
    PRS 12.1%
  • double negative T regulatory cell CL0011024
    CSI 3.8
    rCSI 71.7%
    PRS 49.0%
  • myeloid lineage restricted progenitor cell CL0000839
    CSI 3.8
    rCSI 19.7%
    PRS 13.9%
  • hematopoietic multipotent progenitor cell CL0000837
    CSI 3.9
    rCSI 9.5%
    PRS 11.0%
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 4.1
    rCSI 16.1%
    PRS 11.5%
  • CD14-positive monocyte CL0001054
    CSI 4.3
    rCSI 5.3%
    PRS 10.0%
  • B cell CL0000236
    CSI 4.4
    rCSI 5.9%
    PRS 35.6%
  • common lymphoid progenitor CL0000051
    CSI 4.8
    rCSI 6.4%
    PRS 13.3%
  • unswitched memory B cell CL0000970
    CSI 5.0
    rCSI 4.2%
    PRS 11.5%
  • dendritic cell CL0000451
    CSI 5.2
    rCSI 6.4%
    PRS 23.3%
  • CD8-positive, alpha-beta memory T cell CL0000909
    CSI 5.5
    rCSI 5.8%
    PRS 21.8%
  • CD4-positive, alpha-beta memory T cell CL0000897
    CSI 5.7
    rCSI 4.1%
    PRS 9.4%
  • transitional stage B cell CL0000818
    CSI 5.9
    rCSI 19.4%
    PRS 20.8%
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 6.1
    rCSI 4.1%
    PRS 8.4%
  • activated CD4-positive, alpha-beta T cell CL0000896
    CSI 6.6
    rCSI 6.1%
    PRS 12.7%
  • thymocyte CL0000893
    CSI 6.8
    rCSI 24.1%
    PRS 22.4%
  • gamma-delta T cell CL0000798
    CSI 6.8
    rCSI 8.0%
    PRS 54.0%
  • innate lymphoid cell CL0001065
    CSI 7.0
    rCSI 14.4%
    PRS 11.0%
  • CD4-positive, alpha-beta thymocyte CL0000810
    CSI 7.8
    rCSI 6.3%
    PRS 12.7%
  • hematopoietic precursor cell CL0008001
    CSI 7.9
    rCSI 8.2%
    PRS 11.2%
  • effector memory CD4-positive, alpha-beta T cell CL0000905
    CSI 8.1
    rCSI 11.1%
    PRS 17.2%
  • CD16-positive, CD56-dim natural killer cell, human CL0000939
    CSI 8.6
    rCSI 5.7%
    PRS 19.2%
  • classical monocyte CL0000860
    CSI 8.7
    rCSI 12.8%
    PRS 58.3%
  • early lymphoid progenitor CL0000936
    CSI 8.9
    rCSI 7.9%
    PRS 7.8%
  • memory B cell CL0000787
    CSI 9.8
    rCSI 9.7%
    PRS 29.2%
  • regulatory T cell CL0000815
    CSI 10.0
    rCSI 11.6%
    PRS 22.9%
  • T-helper 17 cell CL0000899
    CSI 10.7
    rCSI 8.5%
    PRS 12.2%
  • CD14-positive, CD16-negative classical monocyte CL0002057
    CSI 11.1
    rCSI 67.0%
    PRS 16.1%
  • follicular B cell CL0000843
    CSI 15.1
    rCSI 55.0%
    PRS 31.5%
  • CD4-positive helper T cell CL0000492
    CSI 15.2
    rCSI 11.5%
    PRS 9.6%
  • group 3 innate lymphoid cell CL0001071
    CSI 15.3
    rCSI 11.5%
    PRS 7.1%
  • common dendritic progenitor CL0001029
    CSI 21.2
    rCSI 26.6%
    PRS 8.8%
  • double negative thymocyte CL0002489
    CSI 21.5
    rCSI 15.0%
    PRS 8.1%
  • plasmacytoid dendritic cell CL0000784
    CSI 23.8
    rCSI 24.1%
    PRS 41.7%
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 30.1
    rCSI 17.8%
    PRS 9.6%
  • promonocyte CL0000559
    CSI 34.2
    rCSI 58.6%
    PRS 9.3%
  • mature B cell CL0000785
    CSI 37.5
    rCSI 32.6%
    PRS 8.5%
  • naive thymus-derived CD4-positive, alpha-beta T cell CL0000895
    CSI 39.5
    rCSI 49.7%
    PRS 34.7%
  • naive B cell CL0000788
    CSI 40.8
    rCSI 35.0%
    PRS 15.6%
  • class switched memory B cell CL0000972
    CSI 49.0
    rCSI 36.6%
    PRS 11.7%
  • plasmacytoid dendritic cell, human CL0001058
    CSI 56.3
    rCSI 39.3%
    PRS 7.3%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [SELL](/details-gene/6402), or Selectin L, encodes the protein L-selectin (also known as CD62L), a cell adhesion molecule crucial for the initial steps of leukocyte trafficking. As a member of the selectin family, it is located on the external side of the plasma membrane and mediates the tethering and rolling of leukocytes along endothelial cells, a prerequisite for their extravasation into lymphoid tissues and sites of inflammation. **Overall**, expression data reveals that [SELL](/details-gene/6402) is a defining marker for various immune cell populations, particularly naive lymphocytes, hematopoietic stem cells, and a subset of natural killer cells, highlighting its fundamental role in immune surveillance and cell homing. Its clinical relevance is noted in OMIM ([153240](https://omim.org/entry/153240)). ## Cellular Roles and Expression Landscape The expression profile of [SELL](/details-gene/6402) firmly establishes it as a key regulator of immune cell localization, with particularly high significance in naive and progenitor cell populations. It is a top marker in cells central to both innate and adaptive immunity, including [CD16-negative, CD56-bright natural killer cell, human](/details-cell/CL0000938), [hematopoietic stem cell](/details-cell/CL0000037), [naive thymus-derived CD8-positive, alpha-beta T cell](/details-cell/CL0000900), and [naive B cell](/details-cell/CL0000788). Its prominence in these cell types, as well as in [plasmacytoid dendritic cell, human](/details-cell/CL0001058) and various memory T and B cell subsets, underscores its critical function in directing the circulation of lymphocytes through secondary lymphoid organs, a process essential for initiating adaptive immune responses. The high significance in hematopoietic stem cells also suggests a role in their trafficking and engraftment within the bone marrow niche. Conversely, the gene's low to negative significance in more differentiated or activated effector cells provides crucial functional context. For instance, [SELL](/details-gene/6402) shows low significance in [CD8-positive, alpha-beta cytotoxic T cell](/details-cell/CL0000794) and [non-classical monocyte](/details-cell/CL0000875). This expression pattern is consistent with the well-documented process of L-selectin shedding from the cell surface upon leukocyte activation. This mechanism is thought to facilitate the release of activated lymphocytes from lymphoid tissues, allowing them to migrate to peripheral sites of inflammation. The low expression in cells like [platelet](/details-cell/CL0000233) further refines its role to specific leukocyte lineages. ## Pathways and Molecular Function The molecular functions and biological pathways associated with [SELL](/details-gene/6402) are highly consistent with its observed cellular expression pattern. Functionally, it acts as a calcium-dependent carbohydrate-binding protein ([GO:0030246](https://www.ebi.ac.uk/QuickGO/term/GO:0030246), [GO:0005509](https://www.ebi.ac.uk/QuickGO/term/GO:0005509)), specializing in binding sialylated carbohydrate structures on other cells. This molecular interaction is the basis for its role in biological processes such as [Leukocyte tethering or rolling](/details-ontology/GO:0050901) and [Leukocyte cell-cell adhesion](/details-ontology/GO:0007159). These functions are integral to several high-level immune system pathways. Reactome analysis places [SELL](/details-gene/6402) in the context of the [Adaptive immune system](/details-pathway/R-HSA-1280218) and [Innate immune system](/details-pathway/R-HSA-168249), with a highly specific role in [Cell surface interactions at the vascular wall](/details-pathway/R-HSA-202733). This pathway describes the initial, low-affinity interactions that allow circulating leukocytes to "roll" along the blood vessel wall, a critical step before firm adhesion and transmigration into tissues. Its involvement in [Immunoregulatory interactions between a lymphoid and a non-lymphoid cell](/details-pathway/R-HSA-198933) further supports its function as a homing receptor guiding lymphocytes to endothelial cells in high endothelial venules of lymph nodes. ## Research Directions The stark contrast in [SELL](/details-gene/6402) significance between naive lymphocytes and their activated effector counterparts points to its role as a critical checkpoint in immune cell differentiation and trafficking. This dynamic regulation is a promising area for further investigation. ### Proposed Hypotheses: 1. The downregulation of [SELL](/details-gene/6402) on T cells following activation is an essential requirement for their effective migration to non-lymphoid tissues. Forced, sustained expression of [SELL](/details-gene/6402) on activated cytotoxic T cells would impair their ability to exit secondary lymphoid organs, thereby trapping them and compromising pathogen clearance in peripheral tissues. 2. Given its top-ranking significance in [CD16-negative, CD56-bright natural killer cell, human](/details-cell/CL0000938), a subset known for its immunoregulatory cytokine production and recirculation capacity, [SELL](/details-gene/6402) is the primary homing receptor directing this specific NK cell subset to lymph nodes. Genetic ablation of [SELL](/details-gene/6402) would disproportionately reduce the number of CD56-bright NK cells in lymph nodes compared to other NK cell populations in the spleen or peripheral blood. ### Experimental Approach: To test the first hypothesis regarding T cell trafficking, one could employ a genetic model. This would involve generating a transgenic mouse where the *Sell* gene is replaced with a version resistant to cleavage/shedding upon T cell activation. T cells from these mice could be isolated, activated *in vitro*, and adoptively transferred into wild-type recipient mice infected with a pathogen like Lymphocytic Choriomeningitis Virus (LCMV). The localization of the modified (non-shedding) versus control T cells in lymph nodes, spleen, and peripheral tissues (e.g., liver, fat) would be quantified using flow cytometry and immunohistochemistry at various time points post-infection. A significant accumulation of modified T cells in lymphoid organs and a corresponding deficit in infected peripheral tissues would support the hypothesis that [SELL](/details-gene/6402) downregulation is a key licensing step for effector T cell tissue exit. ### Therapeutic Potential: As a cell surface adhesion molecule that mediates leukocyte infiltration, [SELL](/details-gene/6402) is a compelling therapeutic target for inflammatory conditions. The primary strategy would be **inhibition**, aiming to block the initial tethering and rolling of leukocytes to prevent their entry into tissues where they cause pathological damage. This makes it a potential target for treating autoimmune diseases like rheumatoid arthritis, inflammatory bowel disease, or acute inflammatory syndromes. Because it is an extracellular protein, it is highly amenable to targeting with monoclonal antibodies or small molecule inhibitors that block its ligand-binding site. However, a potential risk of systemic [SELL](/details-gene/6402) blockade is the impairment of normal immune surveillance, which could increase susceptibility to infections.

Genular Protein ID: 929911993

Symbol: LYAM1_HUMAN

Name: L-selectin

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 2664786

Title: Human homologue of mouse lymph node homing receptor: evolutionary conservation at tandem cell interaction domains.

PubMed ID: 2664786

DOI: 10.1073/pnas.86.14.5562

PubMed ID: 2473156

Title: Isolation and chromosomal localization of cDNAs encoding a novel human lymphocyte cell surface molecule, LAM-1. Homology with the mouse lymphocyte homing receptor and other human adhesion proteins.

PubMed ID: 2473156

DOI: 10.1084/jem.170.1.123

PubMed ID: 2509939

Title: Leu-8/TQ1 is the human equivalent of the Mel-14 lymph node homing receptor.

PubMed ID: 2509939

DOI: 10.1038/342078a0

PubMed ID: 2663882

Title: Characterization of a human homologue of the murine peripheral lymph node homing receptor.

PubMed ID: 2663882

DOI: 10.1083/jcb.109.1.421

PubMed ID: 1692315

Title: Structure of the gene encoding the human leukocyte adhesion molecule-1 (TQ1, Leu-8) of lymphocytes and neutrophils.

PubMed ID: 1692315

DOI: 10.1016/s0021-9258(19)38994-x

PubMed ID: 14702039

Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.

PubMed ID: 14702039

DOI: 10.1038/ng1285

PubMed ID: 16710414

Title: The DNA sequence and biological annotation of human chromosome 1.

PubMed ID: 16710414

DOI: 10.1038/nature04727

PubMed ID: 16335952

Title: Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.

PubMed ID: 16335952

DOI: 10.1021/pr0502065

PubMed ID: 12403782

Title: Molecular basis of leukocyte rolling on PSGL-1. Predominant role of core-2 O-glycans and of tyrosine sulfate residue 51.

PubMed ID: 12403782

DOI: 10.1074/jbc.m204360200

PubMed ID: 12736247

Title: Model glycosulfopeptides from P-selectin glycoprotein ligand-1 require tyrosine sulfation and a core 2-branched O-glycan to bind to L-selectin.

PubMed ID: 12736247

DOI: 10.1074/jbc.m303551200

PubMed ID: 18606703

Title: Endoglycan, a member of the CD34 family of sialomucins, is a ligand for the vascular selectins.

PubMed ID: 18606703

DOI: 10.4049/jimmunol.181.2.1480

PubMed ID: 19349973

Title: Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins.

PubMed ID: 19349973

DOI: 10.1038/nbt.1532

PubMed ID: 7488174

Title: A template for generation and comparison of three-dimensional selectin models.

PubMed ID: 7488174

DOI: 10.1006/bbrc.1995.2722

PubMed ID: 28489325

Title: Reducing Macro- and Microheterogeneity of N-Glycans Enables the Crystal Structure of the Lectin and EGF-Like Domains of Human L-Selectin To Be Solved at 1.9 A Resolution.

PubMed ID: 28489325

DOI: 10.1002/cbic.201700220

PubMed ID: 28011641

Title: Glycan Bound to the Selectin Low Affinity State Engages Glu-88 to Stabilize the High Affinity State under Force.

PubMed ID: 28011641

DOI: 10.1074/jbc.m116.767186

Sequence Information:

  • Length: 372
  • Mass: 42187
  • Checksum: 6EA9918ECA2D3643
  • Sequence:
  • MIFPWKCQST QRDLWNIFKL WGWTMLCCDF LAHHGTDCWT YHYSEKPMNW QRARRFCRDN 
    YTDLVAIQNK AEIEYLEKTL PFSRSYYWIG IRKIGGIWTW VGTNKSLTEE AENWGDGEPN 
    NKKNKEDCVE IYIKRNKDAG KWNDDACHKL KAALCYTASC QPWSCSGHGE CVEIINNYTC 
    NCDVGYYGPQ CQFVIQCEPL EAPELGTMDC THPLGNFSFS SQCAFSCSEG TNLTGIEETT 
    CGPFGNWSSP EPTCQVIQCE PLSAPDLGIM NCSHPLASFS FTSACTFICS EGTELIGKKK 
    TICESSGIWS NPSPICQKLD KSFSMIKEGD YNPLFIPVAV MVTAFSGLAF IIWLARRLKK 
    GKKSKRSMND PY